PQBP3 protein found to play key role in aging and brain disorders

In a recent study published online on August 5 2024 in The EMBO Journal, researchers from Tokyo Medical and Dental University (TMDU) in Japan have uncovered a crucial piece of this puzzle by focusing on the role of a single nucleolar protein.
news-medical.net/news/20240903/PQBP3-protein-found-to-play-key-role-in-aging-and-brain-disorders.aspx

---
@Genica1

New computational tool accurately assesses health through gut microbiome analysis

A team of Mayo Clinic researchers has developed an innovative computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses and other microorganisms within the digestive system, to provide insights into overall well-being.
news-medical.net/news/20240903/New-computational-tool-accurately-assesses-health-through-gut-microbiome-analysis.aspx

---
@Genica1

New method accelerates drug discovery from years to months

Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery.
news-medical.net/news/20240830/New-method-accelerates-drug-discovery-from-years-to-months.aspx

---
@Genica1

Do you enjoy reading this channel?

Perhaps you have thought about placing ads on it?

To do this, follow three simple steps:

1) Sign up: https://telega.io/c/genica1
2) Top up the balance in a convenient way
3) Create an advertising post

If the topic of your post fits our channel, we will publish it with pleasure.

Telega

Advertising in the Telegram channel «Genica Channel For The World» c0fce - Telega.io

Advertising in the telegram channel Genica Channel For The World with a guarantee of placement! Telegram channel «@genica1». Category: Education. Subscribers: 283. Cost of advertising publication: $3.60.

? Learn Virology @Class_Virus

? Cell Biology @arabbioma

? Analytical Chemistry @Online_Shimi

? Biochemistry @Class_Biochem

✈️ Speed Reading @foadzangenehofficial

?? IELTS & TOEFL @EnjoyEnglysh

? Positive Energy @emosubb

☢ Exchange Chemicals @Exchangechemicals

?? English Videos @English_Video_EV

? Laboratory Science @Labmlc

? Hematology @Class_Hemato

? Bacteria Doping @Bacteriology_Doping

?? English Class @EN_Classes

? Genetics World @genesworld1

? Immuno Class @Class_Immuno

? Advanced Biology @Genica1

?‍⚕ Immuno Planning @immunophil

? Biomedicine @haminoandish

? Biotechnology News @Genica_News

? PDF Bank @medbookland

? Human Genetics @EnjoyGenetics

? Clinical Hemato @ClinicalHematology

? Bacteriology @Bacteriology_Torabi

?? English Text @VR_ENGLISH_TEXT

? Pure Knowledge @kalemnab

?? Kids & Teens @EN_4_KIDS

? Pharmacology @EnjoyPharma

? Chemistry Madness @chemistry5

⚗ Organic Chemistry @Class_Chem

? Bacteria Class @Class_microb

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Researchers discuss the concept of immunodiagnosis and explores the potential of artificial intelligence in ID systems for precise tumor immunotherapy.
news-medical.net/news/20230718/Immunodiagnosis-Unleashing-the-potential-of-personalized-immunotherapy.aspx

---
@Genica1

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need.
news-medical.net/news/20231129/C-Paths-TRxA-and-Celdara-Medical-announce-MOU-to-identify-and-advance-promising-new-therapeutics.aspx

---
@Genica_NEWS

New heart organoid model could revolutionize drug development and toxicology studies

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far.
news-medical.net/news/20231128/New-heart-organoid-model-could-revolutionize-drug-development-and-toxicology-studies.aspx

---
@Genica_NEWS

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology, announced today the expansion of their ongoing partnership for companion diagnostic (CDx) development in China.
news-medical.net/news/20231123/AmoyDx-and-CST-Expand-Existing-Partnership-for-the-Development-of-Companion-Diagnostics-(CDx)-to-Support-Precision-Oncology.aspx

---
@Genica_NEWS